FDAnews Announces — How to Validate Electronic GxP Activities: Is Your Documentation Accurate, Comprehensive and Accessible? Webinar, Aug. 6, 2015
Falls Church, VA (PRWEB) July 21, 2015 -- How to Validate Electronic GxP Activities:
Is Your Documentation Accurate, Comprehensive and Accessible?
**FDAnews Webinar**
Aug. 6, 2015 — 1:30 p.m. – 3:00 p.m. EDT
http://www.fdanews.com/electronicgxpactivities
Inadequate validation of electronic record keeping is a frequent citation in FDA 483s and warning letters, and the computer systems involved are critical for ensuring manufacturers have control over their processes.
If a manufacturer has not previously carried out a computer system validation project, they may not be fully aware of the applicable regulatory requirements and how to define the scope of testing.
GxP computer systems that aren’t properly validated can lead to problems both internally — loss of critical data — and externally — regulatory action.
This webinar provides a step-by-step approach to the planning, execution and reporting of computer system validation activities. Validation documents are auditable records which are often reviewed during regulatory inspections. Therefore, it is important to not only perform testing that shows that the system functions as intended, but to adequately document the testing effort and the rationale used to determine the extent of testing. Attendees will also receive tips on how to adequately manage testing resources to save time and money.
Attendees will learn:
• How to prepare for testing;
• Types of planning documents such as a master validation plans and qualification/validation plans;
• How to perform testing in different environments;
• Tips for writing test scripts and 4 characteristics of well-written test scripts;
• 5 advantages to executing test scripts electronically;
• Assembling a team to include technical testing and business process testing;
• How to use GAMP 5 to determine a system’s software category
• Prerequisites for testing such as available documents, definition of components and data for testing different scenarios;
• 5 principles of good documentation practices;
• Do’s and don’ts for executing good documentation practices;
• When annotations are allowed and how to document correctly;
• 4 things not to do when making corrections;
• How to execute screen captures to facilitate third-party reviews;
• Step-by-step approaches to documenting and resolving nonconformances;
• Establishing traceability as proof of system functionality; and
• Reporting on system limitations such as unresolved bugs and enhancements for future versions.
Meet the Presenter:
Chrysa Plagiannos, Senior Validation and Compliance Analyst, Montrium
Chrysa Plagiannos has 12 years’ experience in the pharmaceutical industry with extensive validation experience which includes the validation of manufacturing processes, equipment, facilities, and computerized systems. She also has experience in complaint management, investigation reporting and quality assurance functions. She has a degree in Chemical Engineering from McGill University.
Who Will Benefit:
• Auditors
• Compliance officers
• Data management and statistics personnel
• Engineering and design controls teams
• Executive management
• Investigators
• Manufacturing directors and supervisors
• Pharmaceutical and cGMP auditors
• QA/QC personnel
• R&D staff
• Regulatory/legislative affairs professionals
• Management specialists
• Training personnel
• Validation specialists/scientists/engineers
• Personnel new to the industry
Conference Details:
How to Validate Electronic GxP Activities:
Is Your Documentation Accurate, Comprehensive and Accessible?
**FDAnews Webinar**
Aug. 6, 2015 — 1:30 p.m. – 3:00 p.m. EDT
http://www.fdanews.com/electronicgxpactivities
Tuition:
$287 per site
Easy Ways to Register:
Online: http://www.fdanews.com/electronicgxpactivities
By phone: 888-838-5578 or 703-538-7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
Michelle Butler, FDANEWS, http://www.fdanews.com, +1 (703) 538-7665, [email protected]
Share this article